Microbiology & Infectious Diseases

A Lesotho HIV cohort found dolutegravir resistance in 9.9% of tested patients who met WHO criteria for virological failure.

New research reveals how gut bacteria could help treat colorectal cancer by altering cholesterol metabolism. A microbial metabolite suppressed tumour growth and overcame treatment resistance in preclinical models, offering a potential new approach.

England recorded one mother-to-child HIV transmission among infants with test results in 2022–2023, according to data presented at HIV Glasgow 2026.

Ferrocene-derived carbon nanotubes demonstrated concentration-dependent antibacterial activity against E. coli, highlighting their potential for further antimicrobial research.

A Phase III trial involving 17,701 older adults found that the ExPEC9V vaccine failed to prevent invasive E. coli infections despite strong antibody responses.

A new RT-PCR test detects intestinal enterococci in drinking water within 3–4 hours, offering faster identification of potential faecal contamination.

Olive pollen immunotherapy was linked to improved allergy symptoms and fewer asthma exacerbations, with no severe systemic reactions reported.

Resistant Salmonella may protect probiotics during antibiotic treatment, offering a potential new approach to tackling antimicrobial resistance.